US Drug Recall Register

Is Biotin recalled?

Yes — there is an active recall. 2 ongoing FDA recalls mention Biotin (15 total). Check the affected lots below.

Recalls are matched by product description. A recall usually affects specific lots, not every package of Biotin. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed.

Class II · Moderate risk Ongoing

Biotin for Injection

Reason Lack of Assurance of Sterility

GenoGenix LLC D-0048-2026
Class II · Moderate risk Ongoing

Biotin 5mg/mL

Reason Lack of Assurance of Sterility

TMC Acquisition LLC dba Tailor Made Compounding D-1197-2022
Class II · Moderate risk Terminated

Biotin Solution for Injection

Reason Lack of Assurance of Sterility

Asp Cares NDC 72833-0589-30 D-0261-2022
Class II · Moderate risk Terminated

Minoxidil/Biotin 1.25mg/5mg Capsule

Reason Lack of Processing Controls (lack of assurance of conformity to specifications).

MasterPharm LLC D-1425-2020
Class II · Moderate risk Terminated

D-Biotin 300 mg Capsule

Reason Lack of Processing Controls (lack of assurance of conformity to specifications).

MasterPharm LLC D-1419-2020
Class II · Moderate risk Terminated

Biotin

Reason Lack of Assurance of Sterility

Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0220-3 D-0945-2020
Class II · Moderate risk Terminated

Finasteride/Biotin 1 mg/50 mcg

Reason Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.

MPRX, Inc. dba Medical Park Pharmacy D-0804-2020
Class III · Low risk Terminated

Biotin 10 mg/mL Injection

Reason Failed pH Specification: product does not meet pH label claim.

Auro Pharmacies Inc. DBA Central Drugs D-1082-2019
Class II · Moderate risk Terminated

Biotin Suspension 10mg/mL

Reason Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.

Partell Specialty Pharmacy D-0636-2018
Class II · Moderate risk Terminated

Biotin USP

Reason CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

American Pharmaceutical Ingredients LLC NDC 58597-8142-1 D-0536-2018
Class I · High risk Terminated

Cap-Biotin 100 Mg

Reason Labeling: Label Mix-Up: Products labeled Biotin 100 mg found to contain 4-aminopyridine

Reliable Rexall-A Compounding Pharmacy D-1068-2016
Class II · Moderate risk Terminated

Biotin10 mg/ml Injectable

Reason Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

The Compounding Pharmacy of America D-1446-2015
Class II · Moderate risk Terminated

Biotin Injection

Reason Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.

FVS Holdings, Inc. dba. Green Valley Drugs D-350-2013